scholarly journals PDB35 LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE-2 DIABETES PATIENTS ON BASAL-BOLUS THERAPY UNDER REAL WORLD CONDITIONS IN GERMANY

2009 ◽  
Vol 12 (7) ◽  
pp. A408
Author(s):  
R Bierwirth ◽  
T Kohlmann ◽  
FW Dippel ◽  
W Landgraf ◽  
R Holle
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Real World ◽  
Insulin Detemir ◽  
Treatment Costs ◽  
Lower Treatment ◽  
Basal Bolus ◽  
Diabetes Patients

2327-PUB: Real-World Patient-Reported Outcomes (PROs) with Insulin Glargine 300 U/ml (Gla-300) in Basal Bolus-Treated People with Type 2 Diabetes (T2DM): The MAGE Study

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2327-PUB ◽  
Author(s):  
ANN A. VERHAEGEN ◽  
ANDRÉ SCHEEN ◽  
KATHY C. ALEXANDRE ◽  
JACQUES BRUHWYLER ◽  
IDES M. COLIN
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Real World ◽  
Patient Reported Outcomes ◽  
Patient Reported ◽  
Basal Bolus

scholarly journals Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study

2020 ◽  
Vol 37 (9) ◽  
pp. 3863-3877
Author(s):  
Javier Escalada ◽  
Fabrice Bonnet ◽  
Jasmanda Wu ◽  
Mireille Bonnemaire ◽  
Shaloo Gupta ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Real World ◽  
Diabetes Patients

Author response for "Switching to insulin glargine 300 units/mL in real‐world older type 2 diabetes patients (DELIVER 3)"

2019 ◽  
Author(s):  
Timothy S. Bailey ◽  
Jasmanda Wu ◽  
Fang Liz Zhou ◽  
Rishab A. Gupta MTech ◽  
Arjun A. Menon ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Real World ◽  
Author Response ◽  
Diabetes Patients
Sign in / Sign up

Export Citation Format

Share Document